E
Sell
3/28/2025Downgrade
Structure Therapeutics Inc. (GPCR) was downgraded to E+ from D- on 3/28/2025 due to a decline in the total return index and volatility index.
D
Sell
3/13/2025Upgraded
Structure Therapeutics Inc. (GPCR) was upgraded to D- from E+ on 3/13/2025 due to an increase in the volatility index, growth index and valuation index.
E
Sell
2/21/2025Downgrade
Structure Therapeutics Inc. (GPCR) was downgraded to E+ from D- on 2/21/2025 due to a major decline in the volatility index, total return index and growth index. EBIT declined 37.58% from -$33.32M to -$45.84M, and earnings per share declined from -$1.5807 to -$1.7817.
D
Sell
11/22/2023Downgrade
Structure Therapeutics Inc. (GPCR) was downgraded to D- from D on 11/22/2023 due to a major decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 14.96 to 10.22, total capital declined 8.24% from $214.49M to $196.82M, and net income declined 2.5% from -$23.28M to -$23.86M.
D
Sell
8/7/2023Downgrade
Structure Therapeutics Inc. (GPCR) was downgraded to D from D+ on 8/7/2023 due to a decline in the volatility index and valuation index.
D
Sell
5/24/2023Upgraded
Structure Therapeutics Inc. (GPCR) was upgraded to D+ from D on 5/24/2023 due to an increase in the volatility index.
D
Sell
5/23/2023Upgraded
Structure Therapeutics Inc. (GPCR) was upgraded to D from E on 5/23/2023 due to a noticeable increase in the volatility index and total return index.
E
Sell
5/22/2023None
Structure Therapeutics Inc. (GPCR) was downgraded to E from U on 05/22/2023.
